C7A.026

Clinical Causes: Genetic mutations that affect cell growth and division Family history of neuroendocrine tumors or rectal cancers Certain hereditary syndromes such as Multiple Endocrine Neoplasia (MEN) or neurofibromatosis Environmental factors including exposure to specific chemicals or carcinogens Previous radiation therapy to the pelvic area

Key Symptoms: Rectal bleeding or blood in stool Persistent pain or discomfort in the rectal area A noticeable lump or mass in the rectum Changes in bowel habits such as diarrhea or constipation Unexplained weight loss Feeling of incomplete bowel evacuation Fatigue or general weakness

Diagnosis Path: The diagnosis of a malignant carcinoid tumor of the rectum typically involves a combination of medical assessments, including: - **Physical examination** and digital rectal exam - **Endoscopic procedures**, such as a colonoscopy, to visualize the tumor and obtain tissue samples - **Biopsy** for histopathological analysis to confirm the neuroendocrine origin of the tumor - **Imaging tests**, including CT scans, MRI, or nuclear medicine scans, to determine the extent of spread - **Laboratory tests** measuring hormone levels if functioning tumors produce active hormones Accurate diagnosis is essential for planning effective treatment options and assessing prognosis.

Treatment Protocols: Treatment approaches for a malignant carcinoid tumor of the rectum depend on the tumor's size, location, whether it has spread, and the overall health of the patient. Common treatments include: - **Surgical removal** of the tumor, which may involve local excision or more extensive procedures like rectal resection - **Radiation therapy** to target local tumor control - **Chemotherapy** in cases where the tumor has spread or is aggressive - **Targeted therapies** and **hormone therapy** for certain neuroendocrine tumors - **Peptide receptor radionuclide therapy (PRRT)**, a specialized treatment for tumors that absorb specific radioactive compounds Following treatment, regular follow-up is vital to monitor for recurrence or metastasis. Multidisciplinary care teams often coordinate management to optimize outcomes.